Elite Pharmaceuticals, Inc. Cash and Cash Equivalents
Elite Pharmaceuticals, Inc. (ELTP) had Cash and Cash Equivalents of $7.11 million as of 2024-03-31, per its 10-K filed 2024-07-01.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2024-07-01
- 2024-03-31: Cash and Cash Equivalents, at Carrying Value $7.11M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $5.82M.
- 2023-09-30: Cash and Cash Equivalents, at Carrying Value $8.65M.
- 2023-06-30: Cash and Cash Equivalents, at Carrying Value $9.08M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2024-03-31 | $7.11M 10-K · filed 2024-07-01 | |
| 2023-12-31 | $5.82M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $8.65M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $9.08M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $7.83M 10-K · filed 2024-07-01 | |
| 2022-12-31 | $17.91M 10-Q · filed 2024-02-14 | |
| 2022-09-30 | $18.56M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $19.78M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $8.54M 10-K · filed 2023-06-29 | |
| 2021-12-31 | $7.29M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $4.49M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $4.75M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $3.19M 10-K · filed 2022-06-29 | |
| 2020-12-31 | $5.41M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $4.37M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.79M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.13M 10-K · filed 2021-06-14 | |
| 2019-12-31 | $1.87M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $2.26M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.58M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.28M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $3.68M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $4.71M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $5.64M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $7.18M 10-K · filed 2019-06-21 | |
| 2017-12-31 | $7.24M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $7.56M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $9.57M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $10.59M 10-K · filed 2018-06-14 | |
| 2016-12-31 | $13.28M 10-Q · filed 2018-02-09 | |
| 2016-09-30 | $12.58M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $12.81M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $11.51M 10-K · filed 2018-06-14 | |
| 2015-12-31 | $8.10M 10-Q · filed 2017-02-09 | |
| 2015-09-30 | $9.03M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $11.62M 10-Q · filed 2016-08-09 | $11.62M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $7.46M 10-K · filed 2018-06-14 | |
| 2014-12-31 | $8.27M 10-Q · filed 2016-02-09 | |
| 2014-09-30 | $7.63M 10-Q · filed 2015-12-30 | |
| 2014-06-30 | $8.17M 10-Q · filed 2015-12-30 | $8.17M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $6.94M 10-K · filed 2017-06-14 | $6.94M 10-K · filed 2014-06-30 |
| 2013-12-31 | $1.08M 10-Q · filed 2015-02-17 | |
| 2013-09-30 | $766.20K 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $231.10K 10-Q · filed 2014-08-14 | |
| 2013-03-31 | $369.02K 10-K · filed 2016-06-15 | |
| 2012-12-31 | $65.66K 10-Q · filed 2014-02-14 | |
| 2012-09-30 | $207.34K 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $475.06K 10-Q · filed 2013-08-14 | |
| 2012-03-31 | $668.41K 10-K · filed 2014-06-30 | |
| 2011-12-31 | $568.69K 10-Q · filed 2013-02-14 | |
| 2011-09-30 | $1.34M 10-Q · filed 2012-11-14 | $1.34M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.76M 10-Q · filed 2012-08-14 | |
| 2011-03-31 | $1.83M 10-K · filed 2013-06-21 | |
| 2010-12-31 | $415.19K 10-Q · filed 2012-02-14 | |
| 2010-09-30 | $593.85K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $389.88K 10-Q/A · filed 2011-08-19 | |
| 2010-03-31 | $578.19K 10-K · filed 2012-06-29 |